95 related articles for article (PubMed ID: 31939034)
1. Proposed Definition for Oligometastatic Recurrence in Biliary Tract Cancer Based on Results of Locoregional Treatment: A Propensity-Score-Stratified Analysis.
Morino K; Seo S; Yoh T; Fukumitsu K; Ishii T; Taura K; Morita S; Kaido T; Uemoto S
Ann Surg Oncol; 2020 Jun; 27(6):1908-1917. PubMed ID: 31939034
[TBL] [Abstract][Full Text] [Related]
2. Survival of surgery for recurrent biliary tract cancer: a single-center experience and systematic review of literature.
Miyazaki Y; Kokudo T; Amikura K; Kageyama Y; Takahashi A; Ohkohchi N; Sakamoto H
Jpn J Clin Oncol; 2017 Mar; 47(3):206-212. PubMed ID: 27940488
[TBL] [Abstract][Full Text] [Related]
3. Patients with recurrent biliary tract cancer have a better prognosis than those with unresectable disease: retrospective analysis of a multi-institutional experience with patients of advanced biliary tract cancer who received palliative chemotherapy.
Ikezawa K; Kanai M; Ajiki T; Tsukamoto T; Toyokawa H; Terajima H; Furuyama H; Nagano H; Ikai I; Kuroda N; Awane M; Ochiai T; Takemura S; Miyamoto A; Kume M; Ogawa M; Takeda Y; Taira K; Ioka T
J Hepatobiliary Pancreat Sci; 2014 Feb; 21(2):98-104. PubMed ID: 23798367
[TBL] [Abstract][Full Text] [Related]
4. Survival Benefits of Surgical Resection in Patients with Recurrent Biliary Tract Carcinoma.
Motoyama H; Kobayashi A; Yokoyama T; Shimizu A; Kitagawa N; Notake T; Fukushima K; Masuo H; Yoshizawa T; Miyagawa SI
World J Surg; 2017 Nov; 41(11):2817-2829. PubMed ID: 28717913
[TBL] [Abstract][Full Text] [Related]
5. Usefulness of serum microRNA as a predictive marker of recurrence and prognosis in biliary tract cancer after radical surgery.
Akazawa Y; Mizuno S; Fujinami N; Suzuki T; Yoshioka Y; Ochiya T; Nakamoto Y; Nakatsura T
Sci Rep; 2019 Apr; 9(1):5925. PubMed ID: 30976046
[TBL] [Abstract][Full Text] [Related]
6. Prognostic impact of lung recurrence in patients with biliary tract cancer.
Sumiyoshi T; Uemura K; Shintakuya R; Okada K; Serikawa M; Ishii Y; Arihiro K; Murakami Y; Murashita J; Takahashi S
Langenbecks Arch Surg; 2023 Jul; 408(1):290. PubMed ID: 37522989
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of preoperative inflammatory markers in resectable biliary tract cancer - Validation and comparison of the Glasgow Prognostic Score and Modified Glasgow Prognostic Score in a Western cohort.
Jansson H; Cornillet M; Björkström NK; Sturesson C; Sparrelid E
Eur J Surg Oncol; 2020 May; 46(5):804-810. PubMed ID: 31848078
[TBL] [Abstract][Full Text] [Related]
8. Chemotherapy versus Best Supportive Care in Advanced Biliary Tract Carcinoma: A Multi-institutional Propensity Score Matching Analysis.
Ji JH; Kim YS; Park I; Lee SI; Kim RB; Park JO; Oh SY; Hwang IG; Jang JS; Song HN; Kang JH
Cancer Res Treat; 2018 Jul; 50(3):791-800. PubMed ID: 28838033
[TBL] [Abstract][Full Text] [Related]
9. Oncological outcomes of surgery for recurrent biliary tract cancer: who are the best candidates?
Sakata J; Nomura T; Aono T; Kitami C; Yokoyama N; Minagawa M; Takizawa K; Miura K; Hirose Y; Ichikawa H; Nagahashi M; Shimada Y; Kobayashi T; Wakai T
HPB (Oxford); 2021 Sep; 23(9):1371-1382. PubMed ID: 33558069
[TBL] [Abstract][Full Text] [Related]
10. The impact of peritoneal lavage cytology in biliary tract cancer (KHBO1701): Kansai Hepato-Biliary Oncology Group.
Matsukuma S; Nagano H; Kobayashi S; Wada H; Seo S; Tsugawa D; Okuyama H; Iida K; Ohmura Y; Takeda Y; Miyamoto A; Nakashima S; Yamada T; Ajiki T; Tsuji A; Yoshimura K; Eguchi H; Hatano E; Ioka T;
Cancer Rep (Hoboken); 2021 Apr; 4(2):e1323. PubMed ID: 33283475
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of a sequential treatment strategy with GEMOX-based followed by FOLFIRI-based chemotherapy in advanced biliary tract cancers.
Sebbagh S; Roux J; Dreyer C; Neuzillet C; de Gramont A; Orbegoso C; Hentic O; Hammel P; de Gramont A; Raymond E; André T; Chibaudel B; Faivre S
Acta Oncol; 2016; 55(9-10):1168-1174. PubMed ID: 27333436
[TBL] [Abstract][Full Text] [Related]
12. Patterns of initial disease recurrence after resection of biliary tract cancer.
Jung SJ; Woo SM; Park HK; Lee WJ; Han MA; Han SS; Kim SH; Park SJ; Kim TH; Koh YH; Hong EK
Oncology; 2012; 83(2):83-90. PubMed ID: 22777276
[TBL] [Abstract][Full Text] [Related]
13. Surgical outcomes of multicentric adenocarcinomas of the biliary tract.
Kobayashi S; Konishi M; Kato Y; Gotohda N; Takahashi S; Kinoshita T; Kinoshita T; Kojima M
Jpn J Clin Oncol; 2011 Sep; 41(9):1079-85. PubMed ID: 21875937
[TBL] [Abstract][Full Text] [Related]
14. Second-line chemotherapy in patients with advanced or recurrent biliary tract cancer: a single center, retrospective analysis of 294 cases.
Takahara N; Nakai Y; Isayama H; Sasaki T; Saito K; Oyama H; Kanai S; Suzuki T; Sato T; Hakuta R; Ishigaki K; Takeda T; Saito T; Mizuno S; Kogure H; Tada M; Koike K
Invest New Drugs; 2018 Dec; 36(6):1093-1102. PubMed ID: 30324343
[TBL] [Abstract][Full Text] [Related]
15. Clinical outcomes of salvage chemoradiotherapy for locally recurrent biliary tract cancer.
Il Yu J; Chul Park H; Hoon Lim D; Oh Park J; Suk Park Y; Tae Kim S; Ho Choi S; Wook Choi D; Woong Han I; Seok Heo J
Tumori; 2017 Jul; 103(4):345-352. PubMed ID: 28708225
[TBL] [Abstract][Full Text] [Related]
16. Preoperative serum CA 19-9 level as a predictive factor for recurrence after curative resection in biliary tract cancer.
Chung MJ; Lee KJ; Bang S; Park SW; Kim KS; Lee WJ; Song SY; Chung JB; Park JY
Ann Surg Oncol; 2011 Jun; 18(6):1651-6. PubMed ID: 21210227
[TBL] [Abstract][Full Text] [Related]
17. The prognostic impact of differentiation at the invasive front of biliary tract cancer.
Okubo S; Mitsunaga S; Kato Y; Kojima M; Sugimoto M; Gotohda N; Takahashi S; Hayashi R; Konishi M
J Surg Oncol; 2018 May; 117(6):1278-1287. PubMed ID: 29572828
[TBL] [Abstract][Full Text] [Related]
18. Long-term outcomes of total thyroidectomy versus thyroid lobectomy for papillary thyroid microcarcinoma: comparative analysis after propensity score matching.
Lee J; Park JH; Lee CR; Chung WY; Park CS
Thyroid; 2013 Nov; 23(11):1408-15. PubMed ID: 23509895
[TBL] [Abstract][Full Text] [Related]
19. The efficacy of fluoropyrimidine-based adjuvant chemotherapy on biliary tract cancer after R0 resection.
Kim YS; Jeong CY; Song HN; Kim TH; Kim HJ; Lee YJ; Hong SC
Chin J Cancer; 2017 Jan; 36(1):9. PubMed ID: 28086990
[TBL] [Abstract][Full Text] [Related]
20. Multigene mutational profiling of biliary tract cancer is related to the pattern of recurrence in surgically resected patients.
Conci S; Ruzzenente A; Simbolo M; Bagante F; Rusev B; Isa G; Lawlor RT; Pedrazzani C; Iacono C; Guglielmi A; Scarpa A
Updates Surg; 2020 Mar; 72(1):119-128. PubMed ID: 32020551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
